Skip to main content

Table 2 Association of LHR-I with demographics and disease characteristics

From: Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

FactorsNLHR Intensityp-value*
NegativeWeakModerateStrong
Age at Diagnosis
 < 6013021 (16%)15 (12%)16 (12%)78 (60%)0.22
 ≥ 601029 (9%)9 (9%)10 (10%)74 (73%) 
Serous Carcinoma
 No7214 (19%)5 (7%)10 (14%)43 (60%)0.13
 Yes16016 (10%)19 (12%)16 (10%)109 (68%) 
Pathologic Stage
 I/II6813 (19%)8 (12%)13 (19%)34 (50%) 
 III/IV16417 (10%)16 (10%)13 (8%)118 (72%) 
Silberberg’s Grade
 1277 (26%)3 (11%)2 (7%)15 (56%)0.21
 2 or 320523 (11%)21 (10%)24 (12%)137 (67%) 
Persistent Disease
 No14422 (15%)15 (10%)17 (12%)90 (63%)0.53
 Yes888 (9%)9 (10%)9 (10%)62 (70%) 
  1. *p-value based on Fisher’s exact test